Induced delusional disorder

F5_INDUDEL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F24 Hospital discharge: ICD-9 — 2973 Cause of death: ICD-10 — F24 Cause of death: ICD-9 — 2973 2 out of 7 registries used, show all original rules.	30
4. Check minimum number of events None	30
5. Include endpoints None	30
6. Filter based on genotype QC (FinnGen only)	30

Control definitions (FinnGen only)

Control exclude: F5_SCHIZO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F20-F29
Name in latin: Perturbatio delusionalis inducta

NAME	F5_INDUDEL
CONTROL_EXCLUDE	F5_SCHIZO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F24
HD_ICD_9	2973
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F24
COD_ICD_9	2973
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Induced delusional disorder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	338	196	135
Only index persons	266	155	111
Unadjusted period prevalence (%)
Whole population	0.00	0.01	0.00
Only index persons	0.01	0.01	0.00
Median age at first event (years)
Whole population	49.76	55.04	41.01
Only index persons	42.98	45.65	39.26

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	30	18	12
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	32.04	27.13	39.39

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

+∞

7.59

9.1

0.0

1270.9

—

nmol/l

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

+∞

7.59

7.3

0.0

659.9

—

nmol/l

—

(3019060) Gas panel - Arterial blood

7.17

2.84

2.2

5.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4.73

2.42

2.3

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4.73

2.42

2.0

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4.15

2.38

2.3

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

3.04

2.20

2.6

2.7

8.8

8.6

mmol/l

0.04

(21494755) Public health laboratory ask at order entry panel

0.00

1.90

0.0

1.3

—

(3026008) Bacteria identified in Urine by Culture

2.91

1.76

2.6

2.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2.51

1.49

1.5

2.4

34.2

55.6

u/l

3.12

(3019309) Folate [Moles/volume] in Red Blood Cells

2.86

1.38

1.8

1.4

959.5

1137.7

nmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.66

1.37

1.0

1.5

—

(3023368) Bacteria identified in Blood by Culture

2.50

1.31

2.4

4.4

—

(40768797) Stomach Pathology biopsy report

0.00

1.25

0.0

1.3

—

(3000494) Fungus identified in Specimen by Culture

2.65

1.13

1.6

1.2

—

(3002256) Pathology report gross observation

0.00

1.04

0.0

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2.17

0.97

4.9

3.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2.00

0.92

3.0

3.3

460.8

605.4

ng/l

—

(3015736) pH of Urine

1.93

0.88

3.8

2.5

—

(40758558) Short blood count panel - Blood

2.04

0.87

23.1

6.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.83

0.0

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

237

0.53

0.73

31.6

11.3

34.8

41.7

0.67

199

(1761868) Lipid panel - Serum or Plasma

0.52

0.67

2.0

2.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1.77

0.65

1.7

1.5

103.3

103.5

pmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.63

0.0

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.63

0.0

1.4

—

(3008898) HLA-B27 [Presence]

0.00

0.62

0.0

1.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.00

0.62

0.0

3.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1.72

0.54

1.4

1.3

16.5

23.7

nmol/l

—

(42870588) Differential panel, method unspecified - Blood

1.55

0.41

9.0

5.0

—

(40761511) CBC panel - Blood by Automated count

258

0.65

0.38

16.3

9.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1.49

0.37

5.2

2.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

153

1.44

0.34

4.9

3.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1.42

0.34

9.0

5.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

0.67

0.30

4.8

2.3

—

(3044889) 12 lead EKG panel

146

1.38

0.28

4.2

3.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.22

0.0

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.22

0.0

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.22

0.0

2.5

—

36.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.3

—

395.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.22

0.0

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

0.00

0.22

0.0

5.1

—

4.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.22

0.0

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.1

—

3.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.22

0.0

2.1

—

145.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.22

0.0

1.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.22

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.22

0.0

2.0

—

100.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.3

—

7.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.7

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.21

0.0

1.7

—

(3025941) Bacteria identified in Stool by Culture

0.00

0.21

0.0

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.21

0.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.24

0.20

1.3

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

195

0.81

0.14

2.8

3.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

184

0.82

0.12

3.1

2.7

51.2

45.0

u/l

0.21

178

(3001122) Ferritin [Mass/volume] in Serum or Plasma

107

1.20

0.10

2.4

2.9

44.1

76.4

ug/l

0.90

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1.14

0.09

2.7

2.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

226

0.90

0.08

14.5

9.6

91.1

88.9

ml/min/173m2

0.21

177

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

218

1.24

0.08

5.6

3.6

6.2

5.8

mmol/l

1.63

202

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

102

0.83

0.08

3.4

4.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

109

1.17

0.07

5.9

5.7

8.8

10.4

umol/l

0.55

104

(3018010) Neutrophils/100 leukocytes in Blood

114

0.94

0.00

23.9

4.9

63.2

56.5

1.60

108

(3002030) Lymphocytes/100 leukocytes in Blood

115

0.93

0.00

18.6

5.1

25.4

29.8

1.43

109

(3006504) Eosinophils/100 leukocytes in Blood

111

0.99

0.00

17.2

5.0

1.7

3.0

1.56

104

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

110

1.00

0.00

17.5

5.4

7.2

8.3

0.82

105

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

0.0

2.0

—

24.0

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

2.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.0

4.9

—

9.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.0

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

4.1

—

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.02

0.00

1.7

2.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.00

0.0

2.2

—

8.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

5.0

—

39.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

228

1.04

0.00

3.8

3.3

1.6

1.3

mmol/l

1.24

211

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1.00

0.00

1.2

2.0

2.8

2.7

mg/l

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

5.7

—

0.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

5.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

6.0

—

15.2

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.02

0.00

1.4

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.0

1.7

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

29.1

—

(4268621)

0.00

0.0

2.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

0.00

0.0

8.6

—

23.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

0.00

0.0

1.8

—

3.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

51.9

—

(3011985) Renin [Units/volume] in Plasma

0.00

0.0

1.0

—

22.5

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.0

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

5.7

—

0.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

278.8

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

4.5

—

0.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.2

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3022313) Gas panel - Capillary blood

0.00

0.0

5.5

—

(4027681)

0.00

0.0

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

35.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.2

—

(36304419) Bacteria [Presence] in Urine

0.93

0.00

3.0

2.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.87

0.00

2.0

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.00

0.0

1.3

—

(3022096) Basophils/100 leukocytes in Blood

110

1.00

0.00

17.0

4.9

0.6

0.8

0.67

104

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_INDUDEL and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_INDUDEL.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: F5_INDUDEL – Induced delusional disorder

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Induced delusional disorder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints